We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breast Cancer Detection Not Raised with Adjunct Ultrasonography

By HospiMedica International staff writers
Posted on 08 Apr 2019
A new study suggests that the benefit of adding breast ultrasonography as a supplement to screening mammography for women with dense breasts may not outweigh associated harms.

Researchers at the University of Washington (UW; Seattle, USA), the University of California Davis (UCD; USA), and the American Cancer Society conducted an observational study of two breast cancer surveillance registries from March 2014 to December 2018, with 6,081 screening mammography plus same-day ultrasonography examinations matched to 30,062 screening mammograms without screening ultrasonography in order to compare both breast cancer screening procedures.

The results revealed that women with dense breasts, women who were younger than 50 years, and women with a family history of breast cancer were more likely to receive screening mammography with ultrasonography examinations than screening mammography alone. More...
Cancer detection rate and interval cancer rates were similar among groups, but there were significantly higher rates of false-positive biopsy and short-interval follow-up in the mammography plus ultrasonography group, and a significantly lower predictive value for biopsy recommendation. The study was published on March 18, 2019, in JAMA Internal Medicine.

“Our observational cohort study of ultrasonography screening in women across a range of breast cancer risk found modest, nonsignificant benefits and rates of screening harms that were high and consistent with prior reports,” concluded lead author Janie Lee, MD, MSc, of UW, and colleagues. “To apply supplemental ultrasonography screening with greater effectiveness, we suggest that additional efforts are needed to more accurately identify women who will benefit from supplemental screening.”

Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.

Related Links:
University of Washington
University of California Davis


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: 123RF

AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection

Handheld ultrasound can miss small or faint carotid plaque, creating uncertainty in community screening. This gap makes it harder for frontline clinicians to decide who needs confirmatory imaging, closer... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.